다이아딕 인터내셔널DYAI 주가

Dyadic's Applied Biosolutions Unit Collaborates With Scripps Research To Evaluate Monoclonal Antibody And Vaccine Candidates Targeting Hantaviruses, Including Andes Virus

A series of recently reported hantavirus and Ebola cases worldwide have underscored the importance of pandemic preparedness and highlighted the need to improve the speed, scalability, flexibility, and cost-effectiveness

♻️ 재탕[8-K] 중대 사건 — 8-K

♻️ 재탕12 Health Care Stocks Moving In Thursday's After-Market Session

♻️ 재탕Dyadic International, Inc. (DYAI) Q1 2026 Earnings Call Transcript

Dyadic International, Inc. (DYAI) Q1 2026 Earnings Call May 13, 2026 5:00 PM EDTCompany ParticipantsPing Rawson - Chief Financial OfficerJoseph Hazelton -...

♻️ 재탕Transcript : Dyadic International, Inc., Q1 2026 Earnings Call, May 13, 2026

Presentation Operator MessageOperator Good evening, and welcome to Dyadic International's Q1 2026 Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded

Dyadic International Inc (NASDAQ:DYAI) Q1 Report Beats Revenue Expectations but EPS Miss Triggers 28% After-Market Selloff

Dyadic International (DYAI) beat Q1 2026 revenue estimates by 20.9% but missed EPS forecasts, posting a wider-than-expected loss. The stock fell 28% in after-market trading as investor focus shifted to rising costs.

Transcript: Dyadic International Q1 2026 Earnings Conference Call

Dyadic announces first quarter 2026 financial results and highlights recent company progress

Dyadic International Inc: Dyadic announces first quarter 2026 financial results and highlights recent company progress...

Dyadic International Q1 EPS $(0.05) Misses $(0.04) Estimate, Sales $1.111M Beat $900.000K Estimate

Dyadic International (NASDAQ:DYAI) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 25 percent. This is a 28.57 percent increase over losses of $(0.07) per share

Earnings Scheduled For May 13, 2026